{
 "generic_name": "Atropine Sulfate Injection",
 "slug": "atropine-sulfate-injection",
 "brand_names": [
  "Atropine Sulfate"
 ],
 "fda_status": [
  "Current",
  "To Be Discontinued"
 ],
 "last_fda_update": "11/07/2025",
 "first_posted": "01/01/2012",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Accord Healthcare Inc.",
   "package_ndc": "16729-483-03",
   "presentation": "Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Discontinuation of the manufacture of the drug"
  },
  {
   "company": "Accord Healthcare Inc.",
   "package_ndc": "16729-484-90",
   "presentation": "Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Discontinuation of the manufacture of the drug"
  },
  {
   "company": "Amphastar Pharmaceuticals, Inc.",
   "package_ndc": "76329-3340-1",
   "presentation": "Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Accord Healthcare Inc.",
   "package_ndc": "16729-484-45",
   "presentation": "Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Accord Healthcare Inc.",
   "package_ndc": "16729-525-08",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: mid-September 2026"
  },
  {
   "company": "Accord Healthcare Inc.",
   "package_ndc": "16729-512-43",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "American Regent, Inc.",
   "package_ndc": "0517-1004-25",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-580-20",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Somerset Therapeutics, LLC",
   "package_ndc": "70069-631-25",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Somerset Therapeutics, LLC",
   "package_ndc": "70069-481-10",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6251-10",
   "presentation": "Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Accord Healthcare Inc.",
   "package_ndc": "16729-526-08",
   "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "American Regent, Inc.",
   "package_ndc": "0517-1001-25",
   "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Somerset Therapeutics, LLC",
   "package_ndc": "70069-641-25",
   "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-4910-34",
   "presentation": "Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)\"",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-4911-34",
   "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2)  (NDC 0409-4911-34)\"",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-9630-05",
   "presentation": "Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1630-10",
   "presentation": "Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Medefil, Inc.",
   "package_ndc": "64253-400-91",
   "presentation": "Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  }
 ],
 "changes": []
}